- Home
- SGMT vs PETS Comparison
SGMT vs PETS Comparison
Compare SGMT & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- PETS
- Stock Information
- Founded
- SGMT 2006
- PETS 1996
- Country
- SGMT United States
- PETS United States
- Employees
- SGMT N/A
- PETS N/A
- Industry
- SGMT
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- SGMT
- PETS Consumer Staples
- Exchange
- SGMT Nasdaq
- PETS Nasdaq
- Market Cap
- SGMT 71.2M
- PETS 62.8M
- IPO Year
- SGMT 2023
- PETS N/A
- Fundamental
- Price
- SGMT $3.55
- PETS $3.70
- Analyst Decision
- SGMT Strong Buy
- PETS Sell
- Analyst Count
- SGMT 6
- PETS 2
- Target Price
- SGMT $25.67
- PETS $3.35
- AVG Volume (30 Days)
- SGMT 392.3K
- PETS 111.3K
- Earning Date
- SGMT 05-08-2025
- PETS 06-10-2025
- Dividend Yield
- SGMT N/A
- PETS N/A
- EPS Growth
- SGMT N/A
- PETS N/A
- EPS
- SGMT N/A
- PETS 0.02
- Revenue
- SGMT N/A
- PETS $247,010,000.00
- Revenue This Year
- SGMT N/A
- PETS N/A
- Revenue Next Year
- SGMT N/A
- PETS N/A
- P/E Ratio
- SGMT N/A
- PETS $216.83
- Revenue Growth
- SGMT N/A
- PETS N/A
- 52 Week Low
- SGMT $1.73
- PETS $2.90
- 52 Week High
- SGMT $7.38
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- SGMT 57.81
- PETS 49.90
- Support Level
- SGMT $3.18
- PETS $3.56
- Resistance Level
- SGMT $3.85
- PETS $3.82
- Average True Range (ATR)
- SGMT 0.27
- PETS 0.18
- MACD
- SGMT 0.01
- PETS -0.01
- Stochastic Oscillator
- SGMT 61.04
- PETS 23.33
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.